Arkolith/Insider Trading/TRAW/Form 4

Pauza Charles David

Chief Science Officer VirologyTraws Pharma, Inc. (TRAW) · full profile →Form 4 · filed Apr 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Grant(A)98K——98K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2024Grant(A)503K——503K
Apr 1, 2024Grant(A)333K——333K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-24-001364) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML